Clinical trial / 2020
Porcine placental extract did not significantly reduce overall menopausal symptoms versus placebo, but showed benefits in overweight or early menopausal subgroups.
One hundred menopausal Korean women were randomly assigned to receive either 400 mg/day of porcine placental extract (PPE) or a placebo for 12 weeks. While the Kupperman Index (KMI) decreased in both groups, the overall difference between groups was not statistically significant. However, KMI decreased significantly more with PPE than placebo in women with BMI 23 kg/m2 or higher (-18.52 ± 9.09 vs -11.40 ± 10.68, P < 0.05) and in early menopausal women (-17.29 ± 9.07 vs -11.29 ± 10.68, P < 0.05). Estradiol levels also increased significantly in the PPE group at 12 weeks (11.13 ± 35.13 pg/m, P < 0.05).
- Study type
- Multicenter, randomized, double-blind, placebo-controlled trial
- Who was studied
- 100 menopausal Korean women
- What was measured
- Menopausal symptoms evaluated using the Kupperman Index (KMI); estradiol levels
THE PAPER
Effect of porcine placental extract on menopausal symptoms in postmenopausal women: A prospective, randomized, double-blind, placebo-controlled trial.
Lee JY, Lee C, Yoon SH, Choi H. Taiwan J Obstet Gynecol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.